Platelet-inhibiting drugs are often used after vascular interventions. Patients who require such therapies are often critically ill, are treated in intensive care units and often require long-term ventilation. For long-term ventilation a tracheotomy is necessary, which is usually performed as a percutaneous dilatative tracheotomy (PDT). As part of this intervention, there is (theoretically) an increased risk of bleeding/an increased rate of complications in patients with a antiplatelet therapy. In addition, there are various techniques for performing a PDT. The current study aims to investigate the frequency of bleeding/complications taking into account the technique used in PDT.
Study Type
OBSERVATIONAL
Enrollment
300
Tracheotomy in patients +/- antiplatelet therapy
Neurologische Klinik Bad Salzhausen
Nidda, Germany
RECRUITINGMeasurement of bleeding during Percutaneous Dilational Tracheostomy (PDT) with and without antiplatelet therapy (AP).
* bleeding (yes/no) * intervention (yes/no) * decrease (\>= 1 g/dl) of hemoglobin (yes/no) * number of blood transfusion(s)
Time frame: 3 days
- Does the technique of PDT affect the bleeding rate? - How often are recognizable cartilage pin fractures in the context of a PDT? - Influence of AP and PDT technology on the frequency of need for a blood transfusion?
cartilage pin fractures seen in endoscopy
Time frame: 14 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.